Login
← Go Back
Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/
Stock Price vs Company Growth
1d
9.0%
1w
11.8%
1m
20.7%
3m
33.9%
6m
42.0%
1y
63.7%
5y
25.2%
10y
23.5%
all
27.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 30.1 9.0%
29.6
47.7
Company Overview
Sales
276 Cr
Growth: 8.8%
Profit after Tax
14.5 Cr
Growth: -23.2%
Micro Cap
166 Cr
P/E: 11.5x
Industry P/E: 27.1x
Fundamentals
Sales (Cr) ₹ 276
Growth 8.8%
EBITDA 7.9%
P/S 0.6x
Dividend 0.0%
P/E 11.5x
Book Value ₹ 31.7
PEG Ratio 1.3x
ROE 8.4%
P/B 0.9x
Shareholding Pattern
Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (18)
nexpact
balaxi.o...
iepf
Followers (1)
gmuralik